Beacon Biosignals
Company Mission and Overview
Beacon Biosignals is dedicated to unlocking the power of brain data to transform the diagnosis, treatment, and understanding of neurological and psychiatric conditions. Their mission is to accelerate innovation to deliver life-changing treatments to patients faster.
The company combines advanced AI-driven technology with deep biopharma expertise to drive neuroscience innovation with a focus on scientific rigor and patient-centered solutions.
Leadership and Team
The leadership team includes experts in neuroscience, machine learning, clinical and pharmaceutical research, and product development, led by CEO & Co-Founder Jacob Donoghue, MD, PhD.
Beacon Biosignals supports clinical trials with an end-to-end EEG biomarker platform that integrates FDA-cleared devices and AI analytics to improve drug development and patient care.
